View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

Texas Pacific Land Corp: 2 directors

A director at Texas Pacific Land Corp bought 12 shares at 1,376.900USD and the significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...

Azz Inc: 1 director

A director at Azz Inc sold 14,545 shares at 84.790USD and the significance rating of the trade was 81/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing...

AZZ Inc.: Update to credit considerations

Our credit view of this issuer reflects its status as a leading domestic provider of metal galvanizing and coating solutions, against its somewhat weak interest coverage.

Moody's affirms AZZ Inc.'s ratings

Moody's Ratings ("Moody's") affirmed AZZ Inc.'s ("AZZ") Ba3 Corporate Family Rating (CFR), Ba3-PD Probability of Default Rating (PDR) and the Ba3 rating on the company's senior secured bank credit facilities. The Speculative Grade Liquidity rating of SGL-2 is unchanged. The ratings outlook remains s...

AZZ Inc.: Update to credit considerations

Our credit view of this issuer reflects its strong market position and moderate financial leverage, constrained by its reliance on cyclical end markets.

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: October 29, 2022

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Daily Ratings Report: October 17, 2022

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: August 13, 2022

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

AZZ Inc.: New Issuer: Provider of galvanizing, metal coating and weldi...

AZZ's credit profile is supported by its strong market position and moderate leverage tempered by its acquisitive history and reliance on cyclical end markets

Moody's assigns Ba3 CFR to AZZ Inc.; outlook stable

Moody's Investors Service, ("Moody's") assigned a Ba3 Corporate Family Rating (CFR) to AZZ Inc. (AZZ), a Ba3-PD Probability of Default (PDR) and a Ba3 rating to the company's senior secured credit facilities including a $400 million secured revolving credit facility and a $1.3 billion term loan. The...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Tables: February 26, 2022

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Tables: December 25, 2021

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Daily Ratings Report: December 23, 2021

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Wedbush Research
  • Wedbush Research
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
VYGR VOYAGER THERAPEUTICS INC.
VIRC VIRCO MANUFACTURING CORP.
SAGE SAGE THERAPEUTICS INC.
RGNX REGENXBIO INC.
RARE ULTRAGENYX PHARMACEUTICAL INC.
PRTK PARATEK PHARMACEUTICALS INC
PCRX PACIRA BIOSCIENCES INC.
OMER OMEROS CORPORATION
NVCR NOVOCURE LTD.
NBIX NEUROCRINE BIOSCIENCES INC.
MYOK MYOKARDIA INC.
MGNX MACROGENICS INC.
LXRX LEXICON PHARMACEUTICALS INC.
KURA KURA ONCOLOGY INC.
KPTI KARYOPHARM THERAPEUTICS
ICPT INTERCEPT PHARMACEUTICALS INC.
GBT GLOBAL BLOOD THERAPEUTICS INC
FPRX FIVE PRIME THERAPEUTICS INC.
FATE FATE THERAPEUTICS INC
EPZM EPIZYME INC.
CTMX CYTOMX THERAPEUTICS INC.
CDTX CIDARA THERAPEUTICS
BPMC BLUEPRINT MEDICINES CORP.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
FRX_CN FENNEC PHARMACEUTICALS
SYRS SYROS PHARMACEUTICALS
UTHR UNITED THERAPEUTICS CORPORATION
CLSD CLEARSIDE BIOMEDICAL INC
ALBO ALBIREO PHARMA
OBSN OBSEVA
KALA KALA PHARMACEUTICALS INC.
ARGX ARGENX ADS
MRSN MERSANA THERAPEUTICS
GTHX G1 THERAPEUTICS
BHVN BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
VRNA VERONA PHARMA ADS
AMD ADVANCED MICRO DEVICES INC.
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
SURF SURFACE ONCOLOGY
IDRA IDERA PHARMACEUTICALS
UBX UNITY BIOTECHNOLOGY
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
LQDA LIQUIDIA CORPORATION
REPL REPLIMUNE GROUP
ETTX ENTASIS THERAPEUTICS HOLDINGS
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
HARP HARPOON THERAPEUTICS
TPTX TURNING POINT THERAPEUTICS
ISEE IVERIC BIO
PRVL PREVAIL THERAPEUTICS
KRTX KARUNA THERAPEUTICS INC.
STOK STOKE THERAPEUTICS
IGMS IGM BIOSCIENCES
SWTX SPRINGWORKS THERAPEUTICS
VIE VIELA BIO
IDYA IDEAYA BIOSCIENCES
FUSN FUSION PHARMACEUTICALS INC
KDNY CHINOOK THERAPEUTICS
BDTX INC.
ACET BLACK DIAMOND THERAPEUTICS
ITOS ADICET BIO INC
INZY ITEOS THERAPEUTICS
GBIO INOZYME PHARMA
GRAY GENERATION BIO
CYT GRAYBUG VISION
AVTE CYTEIR THERAPEUTICS
TCRR INC
CMPX AEROVATE THERAPEUTICS
INC.
TCR2 THERAPEUTICS INC
COMPASS THERAPEUTICS
Andreas Argyrides ... (+6)
  • Andreas Argyrides
  • David Nierengarten
  • Dennis Pak
  • Laura Chico
  • Liana Moussatos
  • Robert Driscoll
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
VYGR VOYAGER THERAPEUTICS INC.
SAGE SAGE THERAPEUTICS INC.
RARE ULTRAGENYX PHARMACEUTICAL INC.
PRTK PARATEK PHARMACEUTICALS INC
PCRX PACIRA BIOSCIENCES INC.
OMER OMEROS CORPORATION
NVCR NOVOCURE LTD.
NBIX NEUROCRINE BIOSCIENCES INC.
MYOK MYOKARDIA INC.
MGNX MACROGENICS INC.
LXRX LEXICON PHARMACEUTICALS INC.
KURA KURA ONCOLOGY INC.
KPTI KARYOPHARM THERAPEUTICS
ICPT INTERCEPT PHARMACEUTICALS INC.
GBT GLOBAL BLOOD THERAPEUTICS INC
FPRX FIVE PRIME THERAPEUTICS INC.
FATE FATE THERAPEUTICS INC
EPZM EPIZYME INC.
CTMX CYTOMX THERAPEUTICS INC.
CDTX CIDARA THERAPEUTICS
BPMC BLUEPRINT MEDICINES CORP.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
FRX_CN FENNEC PHARMACEUTICALS
SYRS SYROS PHARMACEUTICALS
UTHR UNITED THERAPEUTICS CORPORATION
CLSD CLEARSIDE BIOMEDICAL INC
ALBO ALBIREO PHARMA
OBSN OBSEVA
KALA KALA PHARMACEUTICALS INC.
ARGX ARGENX ADS
MRSN MERSANA THERAPEUTICS
GTHX G1 THERAPEUTICS
BHVN BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
VRNA VERONA PHARMA ADS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
SURF SURFACE ONCOLOGY
IDRA IDERA PHARMACEUTICALS
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
LQDA LIQUIDIA CORPORATION
REPL REPLIMUNE GROUP
ETTX ENTASIS THERAPEUTICS HOLDINGS
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
HARP HARPOON THERAPEUTICS
TPTX TURNING POINT THERAPEUTICS
ISEE IVERIC BIO
PRVL PREVAIL THERAPEUTICS
KRTX KARUNA THERAPEUTICS INC.
STOK STOKE THERAPEUTICS
IGMS IGM BIOSCIENCES
SWTX SPRINGWORKS THERAPEUTICS
VIE VIELA BIO
IDYA IDEAYA BIOSCIENCES
FUSN FUSION PHARMACEUTICALS INC
KDNY CHINOOK THERAPEUTICS
BDTX INC.
ACET BLACK DIAMOND THERAPEUTICS
ITOS ADICET BIO INC
INZY ITEOS THERAPEUTICS
CYT INOZYME PHARMA
AVTE CYTEIR THERAPEUTICS
TCRR INC
AEROVATE THERAPEUTICS
INC.
TCR2 THERAPEUTICS INC
Jonathan Moreland
  • Jonathan Moreland

Monthly Insider Special Screens: December 1, 2021

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch